Pamicogrel (KBT3022) is a cyclooxygenase (COX) inhibitor.
Pamicogrel is a cyclooxygenase inhibitor with platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion. Pamicogrel also has potential in both prophylaxis and treatment of ischemic brain injury[1].
[1]. Light P. Pamicogrel (Kanebo). IDrugs. 1999 Sep;2(9):938-42.
















